Literature DB >> 10573506

Aortic balloon dilatation for congenital aortic stenosis: report of 90 cases (1986-98).

A Borghi1, G Agnoletti, O Valsecchi, M Carminati.   

Abstract

OBJECTIVE: To review 12 years of experience of balloon aortic valvoplasty in childhood.
DESIGN: Early and mid-term clinical and instrumental evaluation of 104 consecutive balloon aortic valvoplasties performed from 1986 to 1998.
SETTING: A tertiary referral centre for congenital heart disease. PATIENTS: 90 patients with congenital aortic stenosis: 20 neonates (group 1), 16 infants (group 2), and 54 children (group 3).
INTERVENTIONS: Balloon aortic valvotomy. MAIN OUTCOME MEASURES: Doppler and peak to peak aortic gradient before and after valvoplasty, degree of aortic regurgitation before and after valvoplasty, early and late mortality, need for repeat intervention or surgery.
RESULTS: Balloon aortic valvoplasty produced a gradient reduction of > 50% in 59 patients, 12 having a residual peak to peak gradient of > 50 mm Hg. Early mortality included three procedure related and six procedure unrelated deaths. There were no intraprocedural deaths. Grade III aortic regurgitation occurred in 20 patients. Five non-lethal complications occurred. At a mean follow up of 5.1 (group 1), 5.7 (group 2), and 7.6 years (group 3), survival was 75%, 88%, and 96%, respectively. Redilatation was performed in three patients in group 1, one in group 2, and 10 in group 3. Surgery was necessary for six in group 1, one in group 2, and eight in group 3. Freedom from events at last follow up was 50%, 75%, and 64%, respectively. There was a residual maximum Doppler gradient of < 30 mm Hg in 22 patients and > 60 mm Hg in 23; 50 patients have mild to moderate aortic regurgitation.
CONCLUSIONS: Balloon aortic valvoplasty is effective and repeatable and offers good palliation for congenital aortic stenosis in childhood.

Entities:  

Mesh:

Year:  1999        PMID: 10573506      PMCID: PMC1729224          DOI: 10.1136/hrt.82.6.e10

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  20 in total

1.  Percutaneous balloon aortic valvuloplasty: results in 23 patients.

Authors:  Z Lababidi; J R Wu; J T Walls
Journal:  Am J Cardiol       Date:  1984-01-01       Impact factor: 2.778

2.  Balloon aortic valvuloplasty in the young adult with congenital aortic stenosis.

Authors:  H M Rosenfeld; M J Landzberg; S B Perry; S D Colan; J F Keane; J E Lock
Journal:  Am J Cardiol       Date:  1994-06-01       Impact factor: 2.778

3.  Long-term follow-up of valvotomy before 1968 for congenital aortic stenosis.

Authors:  K S Hsieh; J F Keane; A S Nadas; W F Bernhard; A R Castaneda
Journal:  Am J Cardiol       Date:  1986-08-01       Impact factor: 2.778

4.  Short- and midterm results of balloon valvuloplasty for valvular aortic stenosis in children.

Authors:  M Witsenburg; A H Cromme-Dijkhuis; I M Frohn-Mulder; J Hess
Journal:  Am J Cardiol       Date:  1992-04-01       Impact factor: 2.778

5.  Balloon dilatation of the aortic valve after previous surgical valvotomy: immediate and follow up results.

Authors:  N Sreeram; D Kitchiner; D Williams; M Jackson
Journal:  Br Heart J       Date:  1994-06

6.  Critical aortic stenosis in the neonate. A comparison of balloon valvuloplasty and transventricular dilation.

Authors:  R S Mosca; M D Iannettoni; S M Schwartz; A Ludomirsky; R H Beekman; T Lloyd; E L Bove
Journal:  J Thorac Cardiovasc Surg       Date:  1995-01       Impact factor: 5.209

7.  Midterm results of balloon dilation of congenital aortic stenosis: predictors of success.

Authors:  P Moore; E Egito; H Mowrey; S B Perry; J E Lock; J F Keane
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

8.  Independent predictors of immediate results of percutaneous balloon aortic valvotomy in children. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators.

Authors:  B W McCrindle
Journal:  Am J Cardiol       Date:  1996-02-01       Impact factor: 2.778

9.  Aortic valve repair and replacement after balloon aortic valvuloplasty in children.

Authors:  J A Hawkins; L L Minich; R E Shaddy; L Y Tani; G S Orsmond; J E Sturtevant; E C McGough
Journal:  Ann Thorac Surg       Date:  1996-05       Impact factor: 4.330

10.  Contemporary results of balloon valvuloplasty and surgical valvotomy for congenital aortic stenosis.

Authors:  M A Gatzoulis; M L Rigby; E A Shinebourne; A N Redington
Journal:  Arch Dis Child       Date:  1995-07       Impact factor: 3.791

View more
  6 in total

1.  Aortic stenosis: the spectrum of practice.

Authors:  O Khalid; D M Luxenberg; C Sable; O Benavidez; T Geva; B Hanna; R Abdulla
Journal:  Pediatr Cardiol       Date:  2006-11-16       Impact factor: 1.655

2.  Balloon dilation and surgical valvotomy comparison in non-critical congenital aortic valve stenosis.

Authors:  Sergej M Prijic; Vladislav A Vukomanovic; Mila S Stajevic; Bojko B Bjelakovic; Marija D Zdravkovic; Igor N Sehic; Jovan Lj Kosutic
Journal:  Pediatr Cardiol       Date:  2014-11-12       Impact factor: 1.655

3.  The importance of hybrid stage I palliation for neonates with critical aortic stenosis and reduced left ventricular function.

Authors:  Yusuke Misumi; Takaya Hoashi; Koji Kagisaki; Satoshi Yazaki; Masataka Kitano; Kenichi Kurosaki; Isao Shiraishi; Hajime Ichikawa
Journal:  Pediatr Cardiol       Date:  2014-12-06       Impact factor: 1.655

4.  Rapid right ventricular pacing is an alternative to adenosine in catheter interventional procedures for congenital heart disease.

Authors:  I Daehnert; C Rotzsch; M Wiener; P Schneider
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

5.  Balloon aortic valvoplasty in paediatric patients: progressive aortic regurgitation is common.

Authors:  C Balmer; M Beghetti; M Fasnacht; B Friedli; U Arbenz
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

6.  Long term results of percutaneous balloon valvoplasty of congenital aortic stenosis: independent predictors of outcome.

Authors:  O Reich; P Tax; J Marek; V Rázek; J Gilík; V Tomek; V Chaloupecký; H Bartáková; J Skovránek
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.